U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07447518) titled 'Double j Stent Related Symptoms' on Jan. 17, 2025.
Brief Summary: In urology, ureteral stents are used to treat obstructive diseases. Hematuria (54%), fever, discomfort, and lower urinary system symptoms are the predominant symptoms related to ureteral stent.
Study Start Date: Sept. 22, 2022
Study Type: INTERVENTIONAL
Condition:
Lower Urinary Tract Symptoms
Intervention:
DRUG: Tadalafil 5mg
once daily 5mg
DRUG: solidosin
once daily
DRUG: Solfenacin
once dialy
DRUG: Mirabegron
once daily
DRUG: Placebo
once daily
Recruitment Status: COMPLETED
Sponsor: Kafrelsheikh University
Information provided by (Responsible Party...